1. Yusuf S., Joseph P., Rangarajan S. et al. Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study // Lancet. 2020. Vol. 395, N 10 226.
P. 795-808.
2. Шальнова С.А., Деев А.Д. Тенденции смертности в России в начале XXI века (по данным официальной статистики) // Кардиоваскулярная терапия и профилактика. 2011. Т. 10, № 6.
С. 5-10.
3. URL: https://apps.who.int/healthinfo/statistics/mortality/whodpms/ params_ex.php (дата обращения: 05.04.2020)
4. URL: https://www.cdc.gov/nchs/fastats/heart-disease.htm (дата
обращения: 05.04.2020)
5. Российский статистический ежегодник. 2018 : статистический сборник / Росстат. Москва, 2018. 694 с.
6. URL: https://ec.europa.eu/eurostat/statistics-explained/index.php/ Cardiovascular_diseases_statistics#Deaths_from_cardiovascular_ diseases (дата обращения: 05.04.2020)
7. Perk J., De Backer G., Gohlke H. et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts) // Eur. J. Prev. Cardiol. 2012. Vol. 19, N 4. P. 585.
8. Бойцов С.А., Погосова Н.В., Бубнова М.Г. и др. Кардиоваскулярная профилактика 2017. Российские национальные рекомендации // Российский кардиологический журнал. 2018. № 6. С. 7-122.
9. Piepoli M., Abreu A., Albus C. et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 10 societies and by invited experts) // Eur. J. Prev. Cardiol. 2016. Vol. 23, N 11. P. NP1-NP96.